Center-Authored Papers

Filters: Author is True, Lawrence  [Clear All Filters]
2012
Sun Y, Campisi J, Higano C, Beer TM, Porter P, Coleman I, True L, Nelson PS.  2012.  Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B.. Nature medicine. Abstract
2014
Amin MB, Lin DW, Gore JL, Srigley JR, Samaratunga H, Egevad L, Rubin M, Nacey J, Carter BH, Klotz L et al..  2014.  The Critical Role of the Pathologist in Determining Eligibility for Active Surveillance as a Management Option in Patients With Prostate Cancer: Consensus Statement With Recommendations Supported by the College of American Pathologists, International Soci. Archives of pathology & laboratory medicine. Abstract
2015
Delahunt B, Hammond E, Egevad L, Samaratunga H, Srigley JR, Humphrey PA, Rubin M, Epstein JI, Lin DW, Gore JL et al..  2015.  Active surveillance for prostate cancer: the role of the pathologist.. Pathology. 47(1):1-3.
2016
Bianchi-Frias D, Basom R, Delrow JJ, Coleman IM, Dakhova O, Qu X, Fang M, Franco OE, Ericson NG, Bielas JH et al..  2016.  Cells Comprising the Prostate Cancer Microenvironment Lack Recurrent Clonal Somatic Genomic Aberrations.. Molecular cancer research : MCR. 14(4):347-84. Abstract
Murphy C, True L, Vakar-Lopez F, Xia J, Gulati R, Montgomery B, Tretiakova M.  2016.  A novel system for estimating residual disease and pathologic response to neoadjuvant treatment of prostate cancer.. The Prostate. Abstract
Mossanen M, Macleod LC, Chu A, Wright JL, Dalkin B, Lin DW, True L, Gore JL.  2016.  Comparative effectiveness of a patient centered pathology report for bladder cancer care.. The Journal of urology. Abstract